Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

Clinical trial NCT05226780 · TERMINATED

Trial details

NCT number: NCT05226780
Sponsor: Neurocrine Biosciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

SCN8A Developmental and Epileptic Encephalopathy Syndrome

Start date: 2022-07-12
Primary completion: 2025-11-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.